<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235742</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32212</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet B Neuropsychiatr Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. B Neuropsychiatr. Genet.</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4841</issn>
<issn pub-type="epub">1552-485X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28440896</article-id>
<article-id pub-id-type="pmc">5656555</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.b.32540</article-id>
<article-id pub-id-type="manuscript">NIHMS860712</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genome-wide meta-analysis identifies a novel susceptibility signal at <italic>CACNA2D3</italic> for nicotine dependence</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yin</surname>
<given-names>Xianyong</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bizon</surname>
<given-names>Chris</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tilson</surname>
<given-names>Jeffrey</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Yuan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gizer</surname>
<given-names>Ian R.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ehlers</surname>
<given-names>Cindy L.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wilhelmsen</surname>
<given-names>Kirk C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Genetics, and Renaissance Computing Institute, University of North Carolina at Chapel Hill, 120 Mason Farm Road 5000 D, Chapel Hill, NC 27599-7264, United States</aff>
<aff id="A2">
<label>2</label>Department of Psychological Sciences, University of Missouri, 210 McAlester Hall, Columbia, MO 65211, United States</aff>
<aff id="A3">
<label>3</label>Department of Molecular and Cellular Neurosciences, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, United States</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Correspondence to: Kirk C. Wilhelmsen, MD, PhD, Department of Genetics, and Renaissance Computing Institute, University of North Carolina at Chapel Hill, 120 Mason Farm Road 5000 D, Chapel Hill, NC 27599-7264, USA. Tel: 1-919-966-1373; Fax: 1-919-843-4682; <email>kirk_wilhelmsen@med.unc.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>25</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>174</volume>
<issue>5</issue>
<fpage>557</fpage>
<lpage>567</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.b.32540-->
<abstract>
<p id="P1">Nicotine dependence (ND) has a reported heritability of 40–70%. Low-coverage whole-genome sequencing was conducted in 1,889 samples from the UCSF Family study. Linear mixed models were used to conduct genome-wide association tests of ND in this and five cohorts obtained from the database of Genotypes and Phenotypes. Fixed-effect meta-analysis was carried out separately for European (n = 14,713) and African (n = 3,369) participants, and then in a combined analysis of both ancestral groups. The meta-analysis of African participants identified a significant and novel susceptibility signal (rs56247223; P = 4.11 × 10<sup>−8</sup>). Data from the Genotype-Tissue Expression (GTEx) study suggested the protective allele is associated with reduced mRNA expression of <italic>CACNA2D3</italic> in three human brain tissues (P &lt; 4.94 × 10<sup>−2</sup>). Sequence data from the UCSF Family study suggested that a rare nonsynonymous variant in this gene conferred increased risk for ND (P = 0.01) providing further support for <italic>CACNA2D3</italic> involvement in ND. Suggestive associations were observed in six additional regions in both European and merged populations (P &lt; 5.00 × 10<sup>−6</sup>). The top variants were found to regulate mRNA expression levels of genes in human brains using GTEx data (P &lt; 0.05): <italic>HAX1</italic> and <italic>CHRNB2</italic> (rs1760803), <italic>ADAMTSL1</italic> (rs17198023), <italic>PEX2</italic> (rs12680810), <italic>GLIS3</italic> (rs12348139), non-coding RNA for <italic>LINC00476</italic> (rs10759883), and <italic>GABBR1</italic> (rs56020557 and rs62392942). A gene-based association test further supported the relation between <italic>GABBR1</italic> and ND (P = 6.36 × 10<sup>−7</sup>). These findings will inform the biological mechanisms and development of therapeutic targets for ND.</p>
</abstract>
<kwd-group>
<kwd>Nicotine dependence</kwd>
<kwd>genome-wide meta-analysis</kwd>
<kwd>susceptibility genes</kwd>
<kwd>expression quantitative trait locus</kwd>
<kwd>nonsynonymous variants</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>